Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafei Chai

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Translational Oncology|January 25, 2021
Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinomaDafei Chai, Zichun Zhang, Shang Yuchen Shi, et al.
Cancers|June 24, 2022
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent AutophagyDafei Chai, Shang Yuchen Shi, Navid Sobhani, et al.
NPJ Vaccines|August 4, 2023
The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinomaNan Jiang, Yanyan Zheng, Jiage Ding, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
LGALS9 blockade augments vaccine-induced immune responses against prostate cancerBowen Lu, Ning Liu, Wanting Zhao, et al.
International Immunopharmacology|January 17, 2016
A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activityYan Luan, Dafei Chai, Jianjian Peng, et al.
Cell Death & Disease|January 18, 2020
The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell linesMinle Li, Xuping Zhang, Ying Lu, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2023
Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitnessHui Tian, Dafei Chai, Gang Wang, et al.
Frontiers in Immunology|February 16, 2024
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospectsBowen Lu, Jing Ming Lim, Boyue Yu, et al.
Journal for Immunotherapy of Cancer|January 4, 2025
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinomaYanyan Zheng, Jiawei Wang, Guangya Zhao, et al.
Cancer Biology & Therapy|February 7, 2022
The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-βGang Wang, Xiaowan Zhou, Zengli Guo, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Translational Oncology|January 25, 2021
Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinomaDafei Chai, Zichun Zhang, Shang Yuchen Shi, et al.
Cancers|June 24, 2022
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent AutophagyDafei Chai, Shang Yuchen Shi, Navid Sobhani, et al.
NPJ Vaccines|August 4, 2023
The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinomaNan Jiang, Yanyan Zheng, Jiage Ding, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
LGALS9 blockade augments vaccine-induced immune responses against prostate cancerBowen Lu, Ning Liu, Wanting Zhao, et al.
International Immunopharmacology|January 17, 2016
A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activityYan Luan, Dafei Chai, Jianjian Peng, et al.
Cell Death & Disease|January 18, 2020
The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell linesMinle Li, Xuping Zhang, Ying Lu, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2023
Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitnessHui Tian, Dafei Chai, Gang Wang, et al.
Frontiers in Immunology|February 16, 2024
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospectsBowen Lu, Jing Ming Lim, Boyue Yu, et al.
Journal for Immunotherapy of Cancer|January 4, 2025
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinomaYanyan Zheng, Jiawei Wang, Guangya Zhao, et al.
Cancer Biology & Therapy|February 7, 2022
The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-βGang Wang, Xiaowan Zhou, Zengli Guo, et al.
Pageof 6